Transcription activation function of C/EBPα is required for induction of granulocytic differentiation

Blood

Volumn 102, Issue 4, 2003, Pages 1267-1275

  Keeshan, Karen ^c   Santilli, Giorgia ^c   Corradini, Francesca ^c   Perrotti, Danilo ^b   Calabretta, Bruno ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN ALPHA; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E2F;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CELL CYCLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DNA BINDING; FETUS; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GRANULOPOIESIS; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL; TRANSACTIVATION; TRANSCRIPTION INITIATION; WESTERN BLOTTING; WILD TYPE;

EID: 0041737609     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-02-0477     Document Type: Article

References (35)

1. Umek R, Friedman A, McKnight SL. CCAAT/enhancer binding protein: a component of a differentiation switch. Science. 1991;251:288-292.
2. Landschultz WH, Johnson PF, McKnight SL. The DNA binding domain of the rat liver nuclear protein C/EBP is bipartite. Science. 1989;243:1681-1688.
3. Radomska HS, Huettner CS, Zhang, P, Cheng T, Scadden DT, Tenen DG. CCAAT/enhancer binding protein alpha is a regulatory switch sufficient for induction of granulocytic development from bipotential myeloid progenitors. Mol Cell Biol. 1998;18:4301-4314.
4. Wang ND, Finegold MJ, Bradley A, et al. Impaired energy homeostasis in C/EBPalpha knockout mice. Science. 1995;269:1108-1112.
5. Zhang DE, Zhang P, Wong ND, Hetherington CJ, Darlington GJ, Tenen DG. Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT/enhancer binding protein alpha-deficient mice. Proc Natl Acad Sci U S A. 1997;94:569-574.
6. Zhang P, Iwama A, Datta MW, Darlington GJ, Link DC, Tenen DG, Upregulation of interleukin 6 and granulocyte colony-stimulating factor receptors by transcription factor CCAAT/enhancer binding protein (C/EBPalpha) is critical for granulopoiesis. J Exp Med. 1998;188:1173-1184.
7. Lui F, Wu HY, Wesselschmidt R, Komaga T, Link DC. Impaired production and increased apoptosis of neutrophils in granulocyte colony-stimulating factor receptor-deficient mice. Immunity. 1996;5: 491-501.
8. Pabst T, Mueller BV, Zhang P, et al. Dominant-negative mutations of C/EBPa, encoding CCAAT/ enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia. Nat Genet. 2001;27: 263-270.
9. Ossipow V, Descombes P, Schibler U. CCAAT/ enhancer binding protein mRNA is translated into multiple proteins with different transcription activation potentials, Proc Natl Acad Sci U S A. 1993; 90:8219-8223.
10. Calkhoven CF, Bouwman PR, Snippe L, Ab G. Translation start site multiplicity of the CCAAT/ enhancer binding protein mRNA is dictated by a small 5′ open reading frame. Nucleic Acids Res. 1994;22:5540-5547.
11. Ah MR, Hsuh CC, Reisner PD, et al. Evidence for post-transcriptional regulation of C/EBPalpha and C/EBPbeta isoform expression during the lipopolysaccharide-mediated acute-phase response. Mol Cell Biol. 1996;16:2295-2306.
12. Lin FT, McDougold OA, Diehl AM, Lane MD. A 30-kDa alternative translation product of the CCAAT/enhancer binding protein a message: transcriptional activator lacking antimitotic activity. Proc Natl Acad Sci U S A. 1993;90:9606-9610.
13. Gambart AF, Hofmann WK, Kuwano S, et al. Mutations in the gene encoding the transcription factor CCAAT/enhancer binding protein alpha in myelodysplastic syndromes and acute myeloid leukemias. Blood. 2002;99:1332-1340.
14. Perrotti D, Cesi V, Trotta R, et al. BCR/ABL suppresses C/EBPa expression through inhibitory action of hnRNP E2. Nat Genet. 2002;30:48-58.
15. Truong BT, Lee YJ, Lodie TA, et al. CCAAT/enhancer binding proteins repress the leukemic phenotype of acute myeloid leukemia. Blood. 2003;101:1141-1148.
16. Ford AM, Bennett CA, Healy LE, Towatari M, Greaves MF, Enver T. Regulation of the myeloperoxidase enhancer binding proteins PU.1, C/EBP-alpha, -beta, and -delta during granulocytic lineage specification. Proc Natl Acad Sci U S A. 1996;93:10838-10846.
17. Iwama A, Zhang P, Darlington GJ, McKerchen SR, Maki R, Tenen DG. Use of RDA analysis of knockout mice to identify myeloid genes regulated in vivo by PO1 and C/EBPalpha. Nucleic Acids Res. 1998;26:3034-3043.
18. Oelgeschlager M, Nuchprayoon I, Luscher B, Friedman AD. C/EBP, c-Myb, and PU.1 cooperate to regulate the neutrophil elastase promoter. Mol Cell Biol. 1996;16:4717-4725.
19. Smith LT, Hohaus S, Gonzales DA, Dziennis SE, Tenen DG. PU.1 (Spi-1) and C/EBP alpha regulate the granulocyte colony-stimulating factor receptor promoter in myeloid cells. Blood. 1996;88: 1234-1247.
20. Johansen LM, Iwama A, Lodie TA, et al. c-Myc is a critical target for C/EBPa in granulopoiesis. Mol Cell Biol. 2001;21:3789-3806.
21. Timchenko NA, Wilde M, Nakamishi M, Smith JR, Darlington GF. CCAAT/enhancer binding protein (C/EBP) inhibits cell proliferation through the p21 (WAF-/CIP-1/SDI-1) protein. Genes Dev. 1996; 10:804-815.
22. Timchenko NA, Harris TE, Wilde M, et al. CCAAT/ enhancer binding protein alpha regulates p21 protein and hepatocyte proliferation in newborn mice. Mol Cell Biol. 1997; 17:7353-7361.
23. Wang H, lakova P, Wilde M, et al. C/EBPalpha arrests cell proliferation through direct inhibition of Cdk2 and Cdk4. Mol Cell. 2001;8:817-828.
24. Harris TE, Albrecht JH, Nakamishi M, Darlington GJ. CCAAT/enhancer binding protein-a cooperates with p21 to inhibir cyclin-dependent kinase-2 activity and induces growth arrest independent of DNA binding. J Biol Chem. 2001;276:29200-29209.
25. Slomiany BA, D'Arrigo KL, Kelly MM, Kurtz DT. C/EBPa inhibits cell growth via direct repression of E2F-DP-mediated transcription. Mol Cell Biol. 2000;20:5986-5997.
26. , Porse BT, Pedersen T, Xu X, et al. E2F repression by C/EBPa is required for adipogenesis and granulopoiesis in vivo. Cell. 2001;107:247-258.
27. Pear WS, Nolan GP, Scott ML, Baltimore D. Production of high-titer helper-free retrovirus by transient transfection. Proc Natl Acad Sci U S A. 1993;90:8392-8396.
28. Lutz PG, Houzel-Charavel A, Moog-Lutz C, Cayre YE. Myeloblastin is a Myb target gene: mechanisms of regulation in myeloid leukemia cells growth-arrested by retinoic acid. Blood. 2001;97: 2449-2456.
29. Strom DK, Cleveland JL, Chellappan S, Nip J, Hiebert SW. E2F-1 and E2F-3 are functionally distinct in their ability to promote myeloid cell cycle progression and block granulocytic differentiation. Cell Growth Differ. 1998;9:59-69.
30. Zhang P, Nelson E, Radomska HS, et al. Induction of granulocytic differentiation by 2 pathways. Blood. 2002;99:4406-4412.
31. McKnight SL. McBindall - a better name for CCAAT/enhancer binding proteins? Cell. 2001; 107:259-261.
32. Wang X, Scott E, Sawyers CL, Friedman AD. C/EBPa bypasses granulocyte colony-stimulating factor signals to rapidly induce PU.1 gene expression, stimulate granulocytic differentiation, and limit proliferation in 32Dcl3 myeloblasts. Blood. 1999;94:560-571.
33. Muller C, Alunni-Fabbroni M, Kowenz-Leutz E, Mo X, Tommasino M, Leutz A. Separation of C/EBPa-mediated proliferation arrest and differentiation pathways. Proc Natl Acad Sci U S A. 1999;96:7276-7281.
34. Wang H, Goode T, Iakova P, Albrecht JH, Timchenko NA. C/EBPa triggers proteasome-dependent degradation of Cdk4 during growth arrest, EMBO J. 2002;21:930-941.
35. Wu L, Timmers C, Maiti B, et al. The E2F-1-3 transcription factors are essential for cellular proliferation. Nature. 2001;414:457-462.